chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Evening of shot went to emergency room at bottom of her foot then got welts  and fire engine welts all over - in ER until 4AM. Then got worse again. Treated Epinephrine and  Epi-pen and prednisone and Tagamet
Woke up at 1am with rapid heart rate (approx. 160bpm)
p/recv vax pt exp localized edema & redness at inj site w/associated difficulty breathing & malaise; pt sought unspecified MD attention & treated w/benadryl; tylenol & medrol dose pack;
Numbness and tingling of arms within hours of vaccine, progressed to legs . Two days later in the Emergency room with leg weakness. Lumbar puncture with high protein confirmed GBS. I was in the ICU for 3 days and medical unit another 2 days receiving treatment.
Received Td in right arm 23 Oct.  Patient states painful with movement after 1 month.
Pt called EMS for "impending doom". Upon arrival EMS found oxygen saturations 80%, patient just states he feels like he is dying.  Seen in ED and admitted for pneumonia due to COVID-19.
Patient received 4 vaccines in same arm (right).  Mother complained of bruising, swelling and redness to right upper arm.  Parent took child to MD's office, but spoke to nurse only (she did not make a visit note).  Nurse applied cortisone cream and guaze to right upper arm and advised mom to apply ice as necessary for swelling.  Area of redness and swelling was measured at 60mm x 55mm.  Patient had full ROM and no limitations.  Spoke to mother on 4/21/14 and she states he is better and only slight redness remains.
I was grocery shopping and noticed my foot started tingling. While I was walking to put my groceries in the car, my foot started throbbing with pain and I was barely able to put the cart away. By the time I drove home 5 -10 minutes I could barely walk on it. I laid on the couch and noticed I had chills. My husband brought me an icepack for my foot. We noticed swelling by the ankle near the veins. It felt like a blood clot. I tried to get up but it was so painful, I couldn't put any pressure or weight on it. I had to crawl to the bathroom. I laid in bed for about 4 to 5 hours and noticed the pain was lessening. So I got up and realized I was able to put some weight on it. By morning, I don't have any pain or symptoms. My foot is fine.  I'm  able to exercise and walk without any symptoms.
Syncope approximately 10minutes post-vaccination. Came to upon prompting, but quite violent response. Arms thrashed out, but standing upright within seconds asking 'Did I pass out?'. Claimed he has in the past, specifically when donating blood. Pale and perspiring for several minutes. Stated neck somewhat sore, but no head discomfort. Stayed in the recovery area around 30 minutes. Fully recovered before leaving. Refused call to relative or emergency services. Suggested he follow up with provider.
Headache, nausea, chills, body aches, sore joints, overall felt horrible
Narrative: Received initial COVID-19 Moderna series through Facility (3/19/21 and 4/16/21). Received third COVID-19 Moderna dose at Facility 09/30/21. Received notification that patient received third Pfizer COVID-19 vaccine dose 9/13/21. Error detected by database. Unknown if any ADRs.
His nose is also cold; having itching on his head and it spread all over his body during the day/Yesterday he had itches in his head now he has itches in his backside; Nasal congestion; Allergy; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the parent.  A 10 year-old male patient received bnt162b2 (BNT162B2) (Lot number: FL0007) as dose 1 (tris), single for covid-19 immunisation. Relevant medical history included: "ALLERGY" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: FEELING COLD (non-serious), outcome "unknown", described as "His nose is also cold"; PRURITUS (non-serious), outcome "unknown", described as "having itching on his head and it spread all over his body during the day/Yesterday he had itches in his head now he has itches in his backside"; NASAL CONGESTION (non-serious), outcome "unknown", described as "Nasal congestion"; HYPERSENSITIVITY (non-serious), outcome "unknown", described as "Allergy".  Additional information: he is a healthy kid. He is taking Cetirizine because he has allergies and the 'hcp' gave me for 3 months (Further clarification unknown) and when I went there and I asked if it is okay to put the shot because he is taking Cetirizine because he has allergies. He has a 3 months 'pill' and this month is the last one but after that I am not giving him.  No follow-up attempts are possible. No further information is expected.
Information has been received from a physician concerning a 12 year old female with seizures who on 30-JUN-2008 was vaccinated with the second dose of VARIVAX (Oka/Merck). Concomitant therapy included TDAP. On 30-JUN-2008, the patient developed a seizure at her car while leaving from the office. She was brought to the hospital where she was admitted and had a code. She was later transferred to another hospital, where a pacemaker was implanted. On an unspecified date, the patient recovered. The reporting physician considered the seizure and the cardiac arrest to be immediately life-threatening. Additional information has been requested.
headache present 3/27-3/28 Exhaustion 3/27-3/28 Cough 3/28 Sinus pressure 3/28
My left arm shoulder were shot was injected started turning red in injected area an then i felt small  tingling that in shot area 7:00 am in the next  morning on 01/O9/2021 WHICH by that midday my arm shoulder area had turn into a full scale 0f itching , That has continue itching an has not stop  an is so annoying when will this ITCHING STOP!!its been 2days 24/7 HELP!
He took the booster Saturday October 30th. He reports Sunday morning he had severe muscle spasms in his neck which resulted in a severe headache.  He has to sleep sitting up.   He also reported it hurt to swallow.  He received treatment at hospital. He was given pain medication which has not really helped the situation. He is still in pain today but wanted to report this issue to us.  He stated all of his vaccines were Moderna.  - PER THE PERSON WHO TOOK HIS REPORT
Moderna vaccine for COVID 19 Red rash began a week after the vaccine was administered, and has continued until 2/ 26 with some lessening of the redness. Rash extends from the site 3inches wide almost to the elbow fo left arm. Using cold compresses and taking Ibuprofen.
Information has been received concerning a pt who on 03/09/2000 was vaccinated with the first dose of varicella vaccine. On 03/19/2000 the pt developed chickenpox. On 03/20/2000 the pt was examined by a physician who confirmed that the patient had chickenpox with approximately 50 lesions scattered face, trunk extremities and vulva.
Rapid heart beat; Chest pain; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old patient of an unspecified gender received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 05Apr2021 (Batch/Lot Number: EN2613) (at the age of 55-year-old) as 1st dose, single, dose 2 via an unspecified route of administration, administered in Arm Left on 10May2021 (Batch/Lot Number: EN6198) as 2nd dose, single for covid-19 immunisation. Medical history included none. Concomitant medication(s) included zolpidem (ZOLPIDEM) taken for sleep aid, start and stop date were not reported. On an unspecified date in 2021, the patient experienced rapid heart beat and chest pain. No treatment was given for the events. The outcome of the events was unknown.  Follow-up attempts are needed. Additional information has been requested.
One month post second vax, on 07/08/1999, pt began to experience severe flu symptoms. In September, she reportedly experienced similar flu symptoms. She was advised by unspecified individual to forego third dose. The most recent information received 05/15/2000 reports the condition of the vaccinee as unk.
arm pain, rash, pruritus, skin warm to touch, exanthmea - Information has been received from a health care professional concerning a 24 year old white female with a latex allergy who on 03  or 04 Apr 2000 was vaccianted with one dose of varicella virus vaccine live (site unkown).  Subsequently the patient developed a 15 mm erythemic rash a few days before the 17 th.  there were also 2 smaller pox like rashes inside the larger rash,  the smaller pox like rashes itched,  there was no blistering, weeping or scarring, the area was warm to touch and sore.  the rash went away in approximately 5 days after onset.  the patient sought unspecified medial treatment.  subsequently, the patient recovered from the erythmic rash.
Dose administered after more than 1 temperature excursions during a period of 33 weeks on 2021; Dose administered after more than 1 temperature excursions during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Dose administered after more than 1 temperature excursions during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Dose administered after more than 1 temperature excursions during a period of 33 weeks on 2021) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 immunisation.     No Medical History information was reported.    On 20-Mar-2021 at 10:42 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 20-Mar-2021 at 10:42 AM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Dose administered after more than 1 temperature excursions during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Dose administered after more than 1 temperature excursions during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Dose administered after more than 1 temperature excursions during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Dose administered after more than 1 temperature excursions during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient age was reported age 57.75.  No concomitant medication was reported by reporter.  Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. It was reported that each time a vial was put into a cooler, sometimes there was a period of time of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34 or 35 degree Fahrenheit. Temperature recordings were taken using a temperature monitor at every hour.Vial was moved to fridge on 09-Mar-2021 and moved to clinic on 20-Mar-2021. Vial was punctured right before administration. Vial best before use date was 08-Apr-2021. Vial was undergone temperature excursion at 09:00 AM and 10:00 AM with 34 and 37 degree Fahrenheit respectively. After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  No treatment medication was reported by reporter.   This case was linked to MOD-2022-566976 (Patient Link).
Received the first doze of Pfizer vaccine on Monday, October 18, 2021. Beginning on Wednesday morning, October 20, at approximately 7:00 a.m. , I began experiencing twitching and spasms in both legs constantly, and twitching in both eyelids. As of today?s date, Monday, October 25, I am still experiencing all adverse effects mentioned above.
Redness and swelling at injection site. Swelling and redness 38 x 38 mm. Student also endorses pain and states it feels "hot".
shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unspecified age. Information about the patient's concurrent condition, concomitant medication or medical history was not provided. In 2015 the patient was vaccinated with zoster vaccine live(ZOSTAVAX) (strength, dose, route, lot # and expiration date were not reported) as prescribed and/or administered by a healthcare provider for the long-term prevention of shingles and/or zoster-related conditions. At the time of patient's vaccination, patient relied on the warning label affixed to zoster vaccine live(ZOSTAVAX), and the information relayed through patient's healthcare provider(s) that zoster vaccine live(ZOSTAVAX) was effective in preventing shingles on a permanent basis and did not carry any significant risk of adverse effects, which induced patient to be vaccinated. On an unspecified date (reported as subsequent to zoster vaccine live(ZOSTAVAX) inoculation), patient was treated for shingles. As a direct and proximate result of patient's use of the zoster vaccine live(ZOSTAVAX) vaccine, patient has and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. The outcome of shingles was not provided. The lawyer considered shingles to be related to zoster vaccine live(ZOSTAVAX).
I developed a severe multi-drug resistant urinary tract infection. It rendered me to be ventilated and dialyzed.  My blood pressure was very low, and I needed the Sepsis sorted out. I was in ICU for 8 days, 5 of them was ventilation. I was unconscious during the ventilation. I have had Dialysis since then. And now I am still on antibiotics and rehab after the stay in ICU.  This was from February 3 until the 20th of 2023.
approx 4-5 days p/vax parent noted fifty cents size red tender area of lt thigh @ site of vax; dx cellulitis; rx ATB-compresses-resolution
I was very tired; Tingling lips; Flu like symptoms; I had the chills; I went to bed and I woke up again with the chills; Hot flashes; Numbness in both feet, both my feet are having a numbing sensation; Fingers are freezing; This is a spontaneous report from a contactable consumer (patient). A 46-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number looks like EL0140) via an unspecified route of administration on 22Dec2020 at a single dose for COVID-19 immunization. The patient medical history included Asthma, blood pressure and cholesterol. The patient took a blood pressure pill, cholesterol pill, a pill for her stomach and breathing treatment for asthma. On 22Dec2020, the patient received her first COVID Vaccination and started to experience flu like symptoms where she had the chills, hot flashes and numbness in both feet. When she said her fingers were freezing on 22Dec2020, so she went to work this morning, she was not experiencing the numbness or anything but like she had the flu shot, she came home this evening (23Dec2020) but she was very tired so took a bath. She went to bed and woke up again with the chills, her lips tingling and both feet having a numbing sensation. The patient took Tylenol when she came home from work to treat these events. The outcome of the events was not recovered.
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 41-year-old male patient received BNT162b2 (BNT162B2), on 06Nov2021 at 22:00 as dose 3 (booster), single (Lot number: 3Q155BA) at the age of 40 years, in left arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Eosinophilic oesophagitis" (unspecified if ongoing); "Full dose of Moderna followed by Pfizer booster" (unspecified if ongoing), notes: Full dose of Moderna followed by Pfizer booster. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (26Apr2022) Negative; (07May2022) Positive, notes: continue to test positive through 07May2022; (May2022) Positive, notes: continue to test positive through 07May2022. Therapeutic measures were taken as a result of covid-19. Clinical course: Treatment of Covid-19 was started on 21Apr2022 and stopped on 26Apr2022. Adverse event start date and time was provided as 02May2022 11:45 PM. Patient stated that after testing negative on an at-home rapid test on 26Apr2022, and following the isolation and masking protocols, I had an impaction of food in my esophagus due to eosinophilic esophagitis on 02May2022. During the hospital stay, I tested positive on a rapid test and continue to test positive through 07May2022. Symptoms were mild, including lingering cough and some nasal congestion. (Full dose of Moderna followed by Pfizer booster, but the site wouldn't let me enter the Moderna vaccine info.).  No follow up attempts are possible. No further information is expected.
Got shingles shot at 2 PM at health dept. on Mar. 2, 2012. Went in hot tub approx. 5 PM & felt pressure on chest, followed by walking resulting in breathing problems, fatigue & chest pressure, subsided after rest.
IMMEDIATE (WITHIN 3 MINUTES OF VACCINATION) PAIN ALL OVER BODY, CONCENTRATING IN BACK AND LOWER LEGS. SEVERE ENOUGH TO RAISE BLOOD PRESSURE AND PULSE SIGNIFICANTLY. AFTER TYLENOL AND BENADRYL, PAIN SUBSIDED (30 MINUTES).
Itching; Bumps on arm.; This case was reported by a pharmacist via call center representative and described the occurrence of pruritus in a 63-year-old male patient who received Herpes zoster (Shingrix) (batch number unknown, expiry date 26th November 2019) for prophylaxis.   On 11th August 2019, the patient received the 1st dose of Shingrix. In August 2019, less than 3 weeks after receiving Shingrix, the patient experienced pruritus and rash. On an unknown date, the outcome of the pruritus and rash were unknown.   It was unknown if the reporter considered the pruritus and rash to be related to Shingrix.  Additional information received were as follows: The patient experienced itching and bumps on arm. The reporter consented to follow up. The reporter did not had lot number.
CHEST CONGESTION; SORE THROAT; BODY ACHES; HEADACHE; This spontaneous report received from a patient concerned a 42 year old female. The patient's height, and weight were not reported. The patient's past medical history included: covid-19. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 211A21A, and expiry: UNKNOWN) dose was not reported, administered on 26-OCT-2021 for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the patient experienced chest congestion, sore throat, body aches, and headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from headache, chest congestion, sore throat, and body aches. This report was non-serious.
I got my period one week earlier and experienced heavy cramping two weeks prior. My period is usually on time and I dont usually experiencing cramping.
Itchy raised red circle (about the size of a US silver dollar) at injection site with 3 lumps around the injection site. Arm soreness.
CHEST PAINS; This spontaneous report received from a consumer via a company representative via Social media concerned a male of unspecified age, race and ethnic origin. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, batch number and expiry were not reported) dose, start therapy date were not reported 01 total was administered for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient (reporter's nephew) experienced chest pains, and was hospitalized (date unspecified). Number of days hospitalized and discharge information was not reported. As per the reporter, "My nephew is in the hospital today for chest pains following the Johnson and Johnson vaccine that was required by a potential employer" The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of chest pains was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0: 20220661521-COVID-19 VACCINE AD26.COV2.S-chest pains. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable.
PT EXPER.ARTHRITIC PAIN AND POLYNEUROPATHY AFTER ADMIN OF INFLUENZA VIRUS VACCINE. REPORTER NOT SURE IF WYETH OF PARKE-DAVIS PRODUCT WAS USED.
HA/CP/Flushed/SOB/Dizziness after 20minutes-- > was taken to ER
Onset - 23 hrs.  Short term fatigue, headache (2 hrs) responded to 1 alleve.  Swelling at injection site with soreness, followed by itchy rash size of a silver dollar.   Swelling subsided in 2 days.  Rash became tiny dots of scab at day 5.  Still have scabs at day 6.
Three hours afe receiving vaccine, patient developed headache, tightnes in throat & chest. Started Diphenhydramine 25 mg po q4h. That night noted swelling of tongue
Redness, warmth, discomfort, itchiness, bump at injection site.  I noticed some itchiness yesterday and today it has noticeably worsened with the above symptoms
5/18/12 began with rash Dx with erythema multiforme minor. No other meds. No other known triggers. Seen in ER and in follow up office visit.